CIK 0001710072
- Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821725586
- Phone
- +1 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- 4 Other disposition Director disposed of 3,473,543 shares (other)
- 4 Exercise or conversion General Counsel acquired 5,400 shares (option exercise)
- 4 Exercise or conversion General Counsel acquired 5,400 shares (option exercise)
- 4 Exercise or conversion Chief Scientific Officer acquired 172,585 shares (option exercise)
- 4 Open-market sale Chief Scientific Officer sold 479 shares at an average $19.11 ($9,155)
- 4 Open-market sale Chief Scientific Officer sold 69,740 shares at an average $19.91 ($1,388,788)
- 4 Open-market sale Chief Scientific Officer sold 29,451 shares at an average $19.82 ($583,823)
- 4 Open-market sale Chief Scientific Officer sold 44,172 shares at an average $17.88 ($789,909)
- 4 Open-market sale Chief Scientific Officer sold 7,182 shares at an average $18.17 ($130,483)
- 4 Open-market sale Chief Scientific Officer sold 1,270 shares at $18.02 ($22,885)
- 4 Open-market sale Chief Scientific Officer sold 21,028 shares at an average $18.39 ($386,743)
- 4 Open-market sale Chief Scientific Officer sold 5,778 shares at an average $18.24 ($105,409)
- 4 Open-market sale Chief Scientific Officer sold 26,454 shares at an average $17.10 ($452,483)
- 4 Open-market sale Chief Scientific Officer sold 58,546 shares at an average $18.30 ($1,071,422)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 11 · 203 filings